(Jan 19, 2022) | By Heather McKenzie

Two-year-old biotech company Enveda Biosciences believes the answers to humanity’s most challenging diseases can be found by harnessing the complexity of the natural world. Enveda’s home base in Boulder, Colorado – where many ponder the wonders of the Rocky Mountains every day – could not be more fitting.

In June 2021, the company raised $51M in a Series A funding round led by Lux Capital.